Boya Bio: Controlling shareholder completes share increase plan

Boya Bio-Pharmaceutical Group (SZSE:300294) announced that its controlling shareholder, China Resources Medicine Holdings, has completed its planned increase of the company's shares. From November 8, 2024, to May 7, 2025, China Resources Medicine Holdings acquired 6,050,900 shares via the Shenzhen Stock Exchange, representing 1.2000% of Boya Bio's total share capital. The total increase amounted to CNY 18,437.53 million, excluding transaction fees. With this transaction, China Resources Medicine Holdings' total shareholding in Boya Bio has increased to 210,741,093 shares, representing 41.7931% of the company's total share capital. China Resources Medicine Holdings stated the share increase demonstrates confidence in Boya Bio's value and future prospects.